Pulmonx LUNG Cash Flow Statement (2019-2025)

NASDAQ LUNG
$1.85 -0.13 (-6.57%)
At close: Sep 10, 2026 · 4:00 PM EDT
Reported Financials

Pulmonx Quarterly Cash Flow Statement

Periods 25 quarters
Latest Sep 2025

Pulmonx reported cash from operations of -$8.17M and free cash flow of -$8.25M for the quarter ended Sep 2025, down 13.4% year over year. This cash flow statement covers 25 quarters of results from Sep 2019 through Sep 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income
-9.29M-12.54M-12.98M-10.18M-13.00M-15.86M-14.64M-14.17M-14.28M-15.86M-16.20M-14.94M-13.89M-13.76M-15.34M-14.15M-13.14M-14.45M-15.20M-13.96M
Share-based CompensationStock Comp.
0.05M2.27M2.31M2.94M3.01M3.51M4.38M4.30M4.25M4.64M5.86M6.00M5.60M5.67M0.70M0.70M5.52M5.61M6.21M5.17M
Deferred Taxes
-0.01M-0.01M-0.00M0.02M-0.05M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.45M0.21M0.31M0.21M0.05M0.07M0.20M0.17M0.27M0.11M0.53M-0.41M0.16M1.70M-0.15M-0.05M-0.05M0.07M
Cash from OperationsCash from Ops.
-7.23M-9.70M-12.70M-8.30M-10.70M-15.03M-9.57M-10.70M-9.80M-12.64M-7.89M-8.66M-8.41M-11.80M-5.80M-7.21M-6.73M-13.22M-3.91M-8.17M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.51M0.57M0.58M0.62M0.59M0.61M0.61M0.63M0.64M0.65M0.67M0.67M0.69M0.70M0.51M0.30M0.33M0.36M0.26M0.47M
Amortization of Deferred ChargesAmort. Deferred Charges
0.10M0.04M0.10M0.10M0.02M0.02M0.10M0.10M0.01M0.01M0.10M0.10M0.01M0.02M0.10M0.10M0.01M0.01M0.10M0.10M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.12M1.01M1.72M0.09M-0.39M0.28M0.80M-0.17M1.28M-0.53M0.71M1.16M1.76M-1.36M0.57M0.36M1.74M0.72M1.22M-1.41M
Change in InventoryChange Inventory
1.10M1.63M1.50M1.88M1.45M2.02M1.01M1.14M-0.54M0.60M-0.34M0.16M-1.35M1.08M-0.41M-0.60M0.15M-0.41M-0.66M1.02M
Change in Account PayablesChange Payables
0.76M0.30M-0.01M2.61M-2.82M1.26M-0.20M0.01M-0.83M0.87M-0.52M1.00M-1.70M1.64M-0.01M1.35M-0.70M0.51M2.14M0.12M
Change in Accured ExpensesChange Accured Exp.
0.71M1.74M1.18M0.36M1.51M-2.31M1.02M-0.94M2.38M-2.48M2.98M0.42M2.25M-5.98M1.74M0.73M3.98M-4.89M2.53M0.53M
Change in TaxesChange Taxes
-0.07M0.03M-0.12M0.11M-0.00M-0.15M-0.11M0.13M0.04M-0.02M-0.11M0.15M-0.02M0.00M-0.02M0.02M0.07M-0.01M
Other Working Capital ChangesOther WC Changes
-0.03M0.01M0.01M0.07M0.00M-0.03M0.00M-0.02M0.01M-0.01M-0.01M-0.01M0.02M0.01M-0.00M0.03M-0.01M-0.05M0.01M
Investing Activities
Capital ExpendituresCapex
0.62M0.24M0.66M1.62M1.15M0.56M0.30M0.28M0.18M0.47M-0.02M0.16M0.20M0.45M0.47M0.42M0.11M0.37M-0.01M0.08M
Change in Acquisitions & DivestmentsChange Acquisitions
2.50M4.50M3.00M4.25M15.03M15.25M9.75M13.75M11.75M17.25M2.25M11.75M6.67M12.75M15.67M20.54M7.25M8.80M
Cash from Investing ActivitiesCash from Investing
-0.69M-12.53M-1.19M-3.41M-29.12M-5.62M2.08M0.04M-0.73M0.57M-0.81M0.99M-2.75M-2.51M-0.83M6.75M14.07M16.31M5.47M8.71M
Financing Activities
Other financing activitiesOther financing
198.67M0.07M1.31M0.34M0.15M0.21M0.17M0.07M0.19M0.04M0.14M0.06M0.06M0.06M0.02M0.03M0.11M0.11M0.03M0.01M
Cash from Financing ActivitiesCash from Financing
199.76M0.01M3.29M1.00M0.15M1.31M0.13M0.91M0.07M20.72M0.09M0.57M0.02M0.86M-0.02M0.46M0.06M0.66M-0.07M0.18M
Additional items
Exchange Rate EffectFX Effect
-0.06M-0.09M0.00M0.10M0.09M0.02M0.13M0.19M-0.20M0.02M0.02M0.20M-0.21M0.05M-0.05M-0.12M0.19M-0.10M-0.58M0.35M
Change in Cash
191.75M-22.28M-10.58M-10.63M-39.59M-19.31M-7.22M-9.54M-10.67M8.67M-8.59M-6.87M-11.40M-13.39M-6.67M-0.15M7.59M3.65M0.91M1.08M
Free Cash FlowFCF
-7.86M-9.94M-13.36M-9.92M-11.85M-15.59M-9.87M-10.98M-9.98M-13.11M-7.87M-8.82M-8.61M-12.25M-6.27M-7.62M-6.84M-13.59M-3.90M-8.25M
Net Cash FlowNCF
191.84M-22.22M-10.59M-10.71M-39.67M-19.33M-7.36M-9.75M-10.46M8.65M-8.61M-7.11M-11.15M-13.44M-6.66M0.00M7.40M3.75M1.50M0.72M